The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
14
07
2020
accepted:
13
10
2020
pubmed:
7
11
2020
medline:
18
5
2021
entrez:
6
11
2020
Statut:
ppublish
Résumé
The aim of this study was to assess the impact of clinically relevant postoperative pancreatic fistula (CR-POPF) on patient disease-specific survival and recurrence after curative distal pancreatectomy (DP) for pancreatic cancer. This was a retrospective case-control analysis. We examined the data of adult patients with a diagnosis of pancreatic ductal adenocarcinoma (PDAC) of the body and tail of the pancreas undergoing curative DP, over a 10-year period in 12 European surgical departments, from a prospectively implemented database. Among the 382 included patients, 283 met the strict inclusion criteria; 139 were males (49.1%) and the median age of the entire population was 70 years (range 37-88). A total of 121 POPFs were observed (42.8%), 42 (14.9%) of which were CR-POPFs. The median follow-up period was 24 months (range 3-120). Although poorer in the POPF group, overall survival (OS) and disease-free survival (DFS) did not differ significantly between patients with and without CR-POPF (p = 0.224 and p = 0.165, respectively). CR-POPF was not significantly associated with local or peritoneal recurrence (p = 0.559 and p = 0.302, respectively). A smaller percentage of patients benefited from adjuvant chemotherapy after POPF (76.2% vs. 83.8%), but the difference was not significant (p = 0.228). CR-POPF is a major complication after DP but it did not affect the postoperative therapeutic path or long-term oncologic outcomes. CR-POPF was not a predictive factor for disease recurrence and was not associated with an increased incidence of peritoneal or local relapse. ClinicalTrials.gov ID: NCT04348084.
Identifiants
pubmed: 33156465
doi: 10.1245/s10434-020-09310-y
pii: 10.1245/s10434-020-09310-y
doi:
Banques de données
ClinicalTrials.gov
['NCT04348084']
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
3171-3183Références
Tieftrunk E, Demir IE, Schorns S, et al. Pancreatic stump closure techniques and pancreatic fistula formation after distal pancreatectomy: meta-analysis and single-center experience. PLoS ONE. 2018;13(6):e0197553. https://doi.org/10.1371/journal.pone.0197553 .
doi: 10.1371/journal.pone.0197553
pubmed: 29897920
pmcid: 5999073
Diener MK, Seiler CM, Rossion I, et al. Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet. 2011;377(9776):1514–22. https://doi.org/10.1016/s0140-6736(11)60237-7 .
doi: 10.1016/S0140-6736(11)60237-7
pubmed: 21529927
Nakamura M, Wakabayashi G, Miyasaka Y, et al. Multicenter comparative study of laparoscopic and open distal pancreatectomy using propensity score-matching. J Hepatobiliary Pancreat Sci. 2015;22(10):731-6. https://doi.org/10.1002/jhbp.268 .
doi: 10.1002/jhbp.268
pubmed: 26087943
Kleeff J, Diener MK, Z’graggen K, et al. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg. 2007;245(4):573–82.
doi: 10.1097/01.sla.0000251438.43135.fb
Serrano PE, Kim D, Kim PT, et al. Effect of pancreatic fistula on recurrence and long-term prognosis of periampullary adenocarcinomas after pancreaticoduodenectomy. Am Surg. 2016;82(12):1187–1195.
doi: 10.1177/000313481608201225
Dundar HZ, Tasar P, Isik O, et al. Anastomotic leaks at the pancreaticojejunostomy following pancreaticoduodenectomy in patients with pancreatic head adenocarcinoma increases the local recurrence rate. Ann Ital Chir. 2018;89:315–319.
pubmed: 30337513
Nagai S, Fujii T, Kodera Y, et al. Recurrence pattern and prognosis of pancreatic cancer after pancreatic fistula. Ann Surg Oncol. 2011;18(8):2329–37. https://doi.org/10.1245/s10434-011-1604-8 .
doi: 10.1245/s10434-011-1604-8
pubmed: 21327822
Veillette G, Dominguez I, Ferrone C, et al. Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience. Arch Surg. 2008;143(5):476–81. https://doi.org/10.1001/archsurg.143.5.476 .
doi: 10.1001/archsurg.143.5.476
pubmed: 18490557
pmcid: 3806102
Wu W, He J, Cameron JL, Makary M, et al. The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma. Ann Surg Oncol. 2014;21(9):2873–81. https://doi.org/10.1245/s10434-014-3722-6 .
doi: 10.1245/s10434-014-3722-6
pubmed: 24770680
pmcid: 4454347
Peng YP, Zhu XL, Yin LD, et al. Risk factors of postoperative pancreatic fistula in patients after distal pancreatectomy: a systematic review and meta-analysis. Sci Rep. 2017;7(1):185. https://doi.org/10.1038/s41598-017-00311-8 .
doi: 10.1038/s41598-017-00311-8
pubmed: 28298641
pmcid: 5428241
Ferrone CR, Warshaw AL, Rattner DW, et al. Pancreatic fistula rates after 462 distal pancreatectomies: staplers do not decrease fistula rates. J Gastrointest Surg. 2008;12(10):1691–7; discussion 1697–8. https://doi.org/10.1007/s11605-008-0636-2 .
doi: 10.1007/s11605-008-0636-2
pubmed: 18704597
pmcid: 3806097
Ratnayake CBB, Wells C, Hammond J, et al. Network meta-analysis comparing techniques and outcomes of stump closure after distal pancreatectomy. Br J Surg. 2019;106(12):1580–1589. https://doi.org/10.1002/bjs.11291 .
doi: 10.1002/bjs.11291
pubmed: 31626341
Hank T, Sandini M, Ferrone CR, et al. Association between pancreatic fistula and long-term survival in the Era of neoadjuvant chemotherapy. JAMA Surg. 2019;154(10):943–951. https://doi.org/10.1001/jamasurg.2019.2272 .
doi: 10.1001/jamasurg.2019.2272
pubmed: 31411659
pmcid: 6694396
Neeman U, Lahat G, Goykhman Y, et al. Prognostic significance of pancreatic fistula and postoperative complications after pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma. Surgeon. 2020;18(1):24–30. https://doi.org/10.1016/j.surge.2019.07.003 .
doi: 10.1016/j.surge.2019.07.003
pubmed: 31466841
Assifi MM, Zhang S, Leiby BE, et al. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Am Coll Surg. 2013;217(4):621–7. https://doi.org/10.1016/j.jamcollsurg.2013.05.014 .
doi: 10.1016/j.jamcollsurg.2013.05.014
pubmed: 23810574
Murakami Y, Uemura K, Sudo T, et al. Is pancreatic fistula associated with worse overall survival in patients with pancreatic carcinoma? World J Surg. 2015;39(2):500–8. https://doi.org/10.1007/s00268-014-2823-5 .
doi: 10.1007/s00268-014-2823-5
pubmed: 25315091
Ausania F, Cook N, Jamieson N, et al. Impact of pancreatic leaks on survival following pancreaticoduodenectomy. JOP. 2010;11(3):226–9.
pubmed: 20442516
Sperti C, Pasquali C, Piccoli A, et al. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg. 1997;21(2):195–200.
doi: 10.1007/s002689900215
Yamamoto J, Saiura A, Koga R, et al. Improved survival of left-sided pancreas cancer after surgery. Jpn J Clin Oncol. 2010;40(6):530–6. https://doi.org/10.1093/jjco/hyq015 .
doi: 10.1093/jjco/hyq015
pubmed: 20363769
Goh BK, Tan YM, Cheow PC, et al. Outcome of distal pancreatectomy for pancreatic adenocarcinoma. Dig Surg. 2008;25(1):32–8. https://doi.org/10.1159/000117821 .
doi: 10.1159/000117821
pubmed: 18292659
Paye F, Micelli Lupinacci R, Bachellier P, et al. French Surgical Association (AFC). Distal pancreatectomy for pancreatic carcinoma in the era of multimodal treatment. Br J Surg. 2015;102(3):229–36. https://doi.org/10.1002/bjs.9708 .
doi: 10.1002/bjs.9708
pubmed: 25533421
van Erning FN, Mackay TM, van der Geest LGM, et al. Dutch Pancreatic Cancer Group. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis. Acta Oncol. 2018;57(12):1655–1662. https://doi.org/10.1080/0284186x.2018.1518593 .
doi: 10.1080/0284186x.2018.1518593
pubmed: 30264642
Agha R, Abdall-Razak A, Crossley E, et al., for the STROCSS Group. The STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery. Int J Surg. 2019;72:156–165.
doi: 10.1016/j.ijsu.2019.11.002
Tol JAMG, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery. 2014;156(3):591–600. https://doi.org/10.1016/j.surg.2014.06.016 .
doi: 10.1016/j.surg.2014.06.016
pubmed: 25061003
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with valuation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae .
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 15273542
pmcid: 1360123
Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3):584–591.
doi: 10.1016/j.surg.2016.11.014
Sandini M, Ruscic KJ, Ferrone CR, et al. Major complications independently increase long-term mortality after pancreatoduodenectomy for cancer. J Gastrointest Surg. 2019;23(10):1984–1990. https://doi.org/10.1007/s11605-018-3939-y .
doi: 10.1007/s11605-018-3939-y
pubmed: 30225794
Van Der Gaag NA, Harmsen K, Eshuis WJ, et al. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death. Eur J Surg Oncol. 2014;40(5):551–558. https://doi.org/10.1016/j.ejso.2013.12.012 .
doi: 10.1016/j.ejso.2013.12.012
pubmed: 24388408
McMillan MT, Vollmer CM Jr, Asbun HJ, et al. The characterization and prediction of ISGPF grade C fistulas following pancreatoduodenectomy. J Gastrointest Surg. 2016;20(2):262–76. https://doi.org/10.1007/s11605-015-2884-2 .
doi: 10.1007/s11605-015-2884-2
pubmed: 26162925
McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg. 2003;90(2):215–9.
doi: 10.1002/bjs.4038
Law WL, Choi HK, Lee YM, et al. Anastomotic leakage is associated with poor long-term outcome in patients after curative colorectal resection for malignancy. J Gastrointest Surg. 2007;11(1):8–15.
doi: 10.1007/s11605-006-0049-z
Bell SW, Walker KG, Rickard MJ, et al. Anastomotic leakage after curative anterior resection results in higher prevalence of local recurrence. Br J Surg. 2003;90(10):1261–6.
doi: 10.1002/bjs.4219
Winer LK, Dhar VK, Wima K, et al. The impact of tumor location on resection and survival for pancreatic ductal adenocarcinoma. J Surg Res. 2019;239:60–66. https://doi.org/10.1016/j.jss.2019.01.061 .
doi: 10.1016/j.jss.2019.01.061
pubmed: 30802706
Ecker BL, McMillan MT, Allegrini V, et al. Risk factors and mitigation strategies for pancreatic fistula after distal pancreatectomy: analysis of 2026 resections from the International, Multi-institutional Distal Pancreatectomy Study Group. Ann Surg. 2019;269(1):143–149. https://doi.org/10.1097/sla.0000000000002491 .
doi: 10.1097/SLA.0000000000002491
pubmed: 28857813
Strasberg SM, Hall BL. Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg. 2011;213(5):616–26. https://doi.org/10.1016/j.jamcollsurg.2011.07.019 .
doi: 10.1016/j.jamcollsurg.2011.07.019
pubmed: 21871822
Lee MK 4th, Lewis RS, Strasberg SM, et al. Defining the postoperative morbidity index for distal pancreatectomy. HPB (Oxford). 2014;16(10):915–23. https://doi.org/10.1111/hpb.12293 .
doi: 10.1111/hpb.12293
pubmed: 24931404
pmcid: 4238858